ReemHGhalibMD

PubMed

• 6 citations
  High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
  Philippe J. Zamor, Ashley Brown, Douglas E. Dylla, John F. Dillon, Anne F Luetkemeyer, Jordan J. Feld, David Mutimer, Reem Ghalib, Eric Crown, Sandra S. Lovell, Yiran ...> ;The American Journal of Gastroenterology. 2021 Sep 1
• 31 citations
  Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
  Catherine Frenette, Zeid Kayali, Edward Mena, Parvez S. Mantry, Kathryn J. Lucas, Guy W. Neff, Miguel Á. Rodríguez, Paul J. Thuluvath, Ethan M. Weinberg, Bal R. Bhanda...> ;Journal of Hepatology. 2021 Feb 1
• 134 citations
  Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
  Rohit Loomba, Mazen Noureddin, Kris V. Kowdley, Anita Kohli, Aasim Sheikh, Guy Neff, Bal R. Bhandari, Nadege Gunn, Stephen H. Caldwell, Zachary Goodman, Ilan Wapinski,...> ;Hepatology. 2021 Feb 1
• 169 citations
  Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
  Naga Chalasani, M. Abdelmalek, Guadalupe Garcia-Tsao, Raj Vuppalanchi, Naim Alkhouri, Mary E. Rinella, Mazen Noureddin, Maxmillan Pyko, Mitchell L. Shiffman, Arun J. S...> ;Gastroenterology. 2020 Apr 1
• 12 citations
  Survey of Women Physicians' Experience with Elected Leadership Positions
  Sasha K. Shillcutt, Sareh Parangi, Sarah Diekman, Reem Ghalib, Robin Schoenthaler, Linda M. Girgis, Ranna Parekh, Hansa Bhargava, Julie K. Silver> ;Health Equity. 2019 Apr 26
• 92 citations
  Analysis of Gender Equity in Leadership of Physician-Focused Medical Specialty Societies, 2008-2017.
  Julie K. Silver, Reem Ghalib, Julie A. Poorman, Dana Al-Assi, Sareh Parangi, Hansa Bhargava, Sasha K. Shillcutt> ;JAMA Internal Medicine. 2019 Mar 1
• 128 citations
  Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonser...
  Saumya Jayakumar, Michael S. Middleton, Eric Lawitz, Parvez S. Mantry, Stephen H. Caldwell, Hays Arnold, Anna Mae Diehl, Reem Ghalib, Magdy Elkhashab, Manal F. Abdelma...> ;Journal of Hepatology. 2019 Jan 1
• 214 citations
  Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
  Stephen A. Harrison, Manal F. Abdelmalek, Stephen H. Caldwell, Mitchell L. Shiffman, Anna Mae Diehl, Reem Ghalib, Eric Lawitz, Don C. Rockey, Raul Aguilar Schall, Cath...> ;Gastroenterology. 2018 Oct 1
• 2 citations
  Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials.
  Philippe J Zamor, John M Vierling, Reem Ghalib, Velimir Luketic, Natarajan Ravendhran, Luis A. Balart, Michael Robertson, Peggy Hwang, George J Hanna, Bach-Yen Nguyen,...> ;The American Journal of Gastroenterology. 2018 Apr 26
• Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection.
  Sulkowski, M. S.,Feld, J. J.,Lawitz, E.,Felizarta, F.,Corregidor, A. M.,Khalid, O.,Ghalib, R.,Smith, W. B.,Van Eygen, V.,Luo, D.,Vijgen, L.,Gamil, M.,Kakuda, T. N.,Ouw...> ;J. Viral Hepat.. 2017 Dec 24
• 251 citations
  Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open...
  Xavier Forns, Samuel S. Lee, Joaquin Mario Valdes, Sabela Lens, Reem Ghalib, Humberto Aguilar, Franco Felizarta, Tarek Hassanein, Holger Hinrichsen, Diego Rincón, Rosa...> ;The Lancet. Infectious Diseases. 2017 Oct 1
• 1 citations
  Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection.
  Maribel Rodriguez-Torres, Eric Lawitz, Bienvenido G. Yangco, Lennox J. Jeffers, Steven Han, Paul J. Thuluvath, Vinod K. Rustgi, Stephen A. Harrison, Reem Ghalib, John ...> ;Annals of Hepatology. 2016 Nov 1
• 146 citations
  Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2)
  Eric Lawitz, Gary Matusow, Edwin DeJesus, Eric M. Yoshida, Franco Felizarta, Reem Ghalib, Eliot Godofsky, Robert Herring, Gary Poleynard, Aasim Sheikh, Hillel Tobias, ...> ;Hepatology. 2016 Aug 1
• 11 citations
  A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1.
  Harvey A Tatum, Paul J. Thuluvath, Eric Lawitz, Claudia Martorell, M. Demicco, S. Cohen, Vinod K. Rustgi, Natarajan Ravendhran, Reem Ghalib, J. Hanson, J. Zamparo, J. ...> ;Journal of Viral Hepatitis. 2015 Aug 1
• 396 citations
  Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Random...
  Stefan Zeuzem, Reem Ghalib, K. Rajender Reddy, Paul J. Pockros, Ziv Ben Ari, Yue Zhao, Deborah D. Brown, Shuyan Wan, Mark J. DiNubile, Bach-Yen Nguyen, Michael N. Robe...> ;Annals of Internal Medicine. 2015 Jul 7
• 498 citations
  All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
  David R. Nelson, James N. Cooper, Jacob Lalezari, Eric Lawitz, Paul J. Pockros, Norman Gitlin, B. Freilich, Ziad Younes, William Harlan, Reem Ghalib, Godson Oguchi, Pa...> ;Hepatology. 2015 Apr 1
• 226 citations
  Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype...
  Eric Lawitz, Edward Gane, Brian L. Pearlman, Edward Tam, Wayne Ghesquiere, Dominique Guyader, Laurent Alric, Jean-Pierre Bronowicki, Laura Lester, William Sievert, Ree...> ;Lancet. 2015 Mar 21
• 110 citations
  A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
  Andrew J. Muir, Sanjeev Arora, Gregory T. Everson, Robert Flisiak, Jacob George, Reem Ghalib, Stuart C. Gordon, T. Gray, Susan Greenbloom, Tarek Hassanein, J. Hillson,...> ;Journal of Hepatology. 2014 Dec 1
• 613 citations
  Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribav...
  Eric Lawitz, Mark S. Sulkowski, Reem Ghalib, Maribel Rodriguez-Torres, Zobair M. Younossi, Ana Corregidor, Edwin DeJesus, Brian L. Pearlman, Mordechai Rabinovitz, Norm...> ;Lancet. 2014 Nov 15
• 1058 citations
  Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
  Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson, Eric Lawitz, Stuart C. Gordon, Eugene R. Schiff, Ronald Nahass, Reem Ghalib, Norman Gitlin, Robert Herring, Jacob ...> ;The New England Journal of Medicine. 2014 Apr 16
• 15 citations
  Peginterferon-α-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantation.
  Fredric D. Gordon, Paul Y. Kwo, Reem Ghalib, Jeffrey S. Crippin, Hugo E. Vargas, Kimberly A Brown, Thomas D. Schiano, Eirum Chaudhri, Lisa D. Pedicone, Robert S. Brown> ;Journal of Clinical Gastroenterology. 2012 Sep 1
• 125 citations
  Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a t...
  Stanislas Pol, Reem Ghalib, Vinod K. Rustgi, Claudia Martorell, G.T. Everson, Harvey A Tatum, Christophe Hézode, Joseph K. Lim, Jean-Pierre Bronowicki, Gary A Abrams, ...> ;The Lancet. Infectious Diseases. 2012 Sep 1
• 494 citations
  Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
  Anna S. Lok, David F. Gardiner, Eric Lawitz, Claudia Martorell, Gregory T. Everson, Reem Ghalib, Robert Reindollar, Vinod K. Rustgi, Fiona McPhee, Megan Wind-Rotolo, A...> ;The New England Journal of Medicine. 2012 Jan 18
• 42 citations
  Racial differences in hepatitis C treatment eligibility
  Michael T. Melia, Andrew J. Muir, Jonathan McCone, Mitchell L. Shiffman, John W. King, Steven K. Herrine, Greg Galler, Joseph R. Bloomer, Frederick A. Nunes, Kimberly ...> ;Hepatology. 2011 Jul 1
• 561 citations
  Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
  Alexander J. Thompson, Andrew J. Muir, Mark S. Sulkowski, Dongliang Ge, Jacques Fellay, Kevin V. Shianna, Thomas J. Urban, Nezam H. Afdhal, Ira M. Jacobson, Rafael Est...> ;Gastroenterology. 2010 Jul 1
• Join now to see all